During a live event, Gary J. Schiller, MD, explored the outcomes of the phase 1/2 trial of tagraxofusp-erzs in patients with ...

As Head of R&D and a member of the Executive Leadership Team, the Company's research, development and medical affairs ...

Sanyou Biopharmaceuticals, a leading Shanghai-based high-tech biopharmaceutical company specializing in biologics R&D today announced the signing of a strategic cooperation agreement with Medicovestor ...

Before joining Priovant, the new Abcuro executive spent more than a decade at Genzyme before its acquisition by Sanofi, ...